Advertisement
News
Advertisement

Epigenetic Factor Can Control Carcinoma Spread

Thu, 05/09/2013 - 10:31am
Very little has been known about the epigenetic events— developmental and environmental factors affecting genes— that occur prior to the invasive growth of head and neck squamous cell carcinomas and their spread to other parts of the body, or metastasis.
 
However, researchers from the UCLA School of Dentistry discovered what could be a crucial step toward understanding the process that activates the cancer cells. Squamous cell carcinoma is known for being one of the most deadly and debilitating types of tumors.
 
Led by Dr. Cun-Yu Wang, a UCLA School of Dentistry professor and leading cancer scientist, the group identified the key epigenetic factor KDM4A, which modifies the molecular activation process of protein AP-1. AP-1 is known to regulate gene expression and promote metastasis of squamous cell carcinoma. Their findings show that squamous cell carcinoma's invasive growth could potentially be repressed by targeting KDM4A.
 
The research team compared two groups of mice with squamous cell carcinoma— one with low levels of KDM4A and one with higher levels of the enzyme. They found that the depletion of KDM4A significantly inhibited squamous cell carcinoma from invading and spreading into the mice's lymph nodes.
 
By understanding the mechanics behind the gene activation process of the AP-1 protein, the team was able to isolate the KDM4A enzyme. The team discovered that the enzyme is required for turning on the genes that promote the activation of AP-1, which is responsible for the growth of the squamous cell carcinoma tumors.
 
Human squamous cell carcinoma is highly invasive and frequently spreads to cervical lymph nodes. Understanding the molecular and epigenetic mechanisms that control the metastasis of squamous cell carcinoma in humans will help scientists develop new therapies for treating cancer.  
 
Authors include Dr. Xiangming Ding, Dr. Hongya Pan, Dr. Jiong Li, Dr. Qi Zhong and Dr. Xiaohong Chen, all from the division of oral biology and medicine at the UCLA School of Dentistry; Dr. Sarah Dry, of UCLA's Jonsson Comprehensive Cancer Center; and Wang, lead author of the study.
 
Wang is the No-Hee Park Endowed Chair in Dentistry at the UCLA School of Dentistry, where he is also chair of the division of oral biology and medicine and the associate dean for graduate studies.
 
This study, published in Science Signaling, a peer-reviewed scientific journal published by the American Association for the Advancement of Science, was supported in part by grants from the National Institute of Dental and Craniofacial Research of the National Institutes of Health and the Shapiro Family Charitable Foundation.
 
Source: UCLA
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading